293 related articles for article (PubMed ID: 16919168)
1. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding--a European perspective.
Vincent JL; Rossaint R; Riou B; Ozier Y; Zideman D; Spahn DR
Crit Care; 2006; 10(4):R120. PubMed ID: 16919168
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.
Martinowitz U; Michaelson M;
J Thromb Haemost; 2005 Apr; 3(4):640-8. PubMed ID: 15842347
[TBL] [Abstract][Full Text] [Related]
3. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
[TBL] [Abstract][Full Text] [Related]
4. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
5. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
[TBL] [Abstract][Full Text] [Related]
6. The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma.
Geeraedts LM; Kamphuisen PW; Kaasjager HA; Verwiel JM; van Vugt AB; Frölke JP
Injury; 2005 Apr; 36(4):495-500. PubMed ID: 15755430
[TBL] [Abstract][Full Text] [Related]
7. "Off-license" use of recombinant activated factor VII.
Ghorashian S; Hunt BJ
Blood Rev; 2004 Dec; 18(4):245-59. PubMed ID: 15501553
[TBL] [Abstract][Full Text] [Related]
8. Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma.
Shamsi T; Tufail M; Aftab M; Ansari S
J Pak Med Assoc; 2006 May; 56(5):238-41. PubMed ID: 16767955
[TBL] [Abstract][Full Text] [Related]
9. Recombinant factor VIIa in the treatment of non-hemophiliac bleeding.
Lam MS; Sims-McCallum RP
Ann Pharmacother; 2005 May; 39(5):885-91. PubMed ID: 15784806
[TBL] [Abstract][Full Text] [Related]
10. Recombinant activated coagulation factor VII and bleeding trauma patients.
Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of recombinant activated factor VII in unselected patients with uncontrolled haemorrhage: a single centre experience.
Payne EM; Brett SJ; Laffan MA
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):397-402. PubMed ID: 16788316
[TBL] [Abstract][Full Text] [Related]
12. Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?
Poon MC
Curr Hematol Rep; 2003 Mar; 2(2):139-47. PubMed ID: 12901145
[TBL] [Abstract][Full Text] [Related]
13. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
Murkin JM
Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
[TBL] [Abstract][Full Text] [Related]
14. [Activated recombinant factor VII (Novoseven) in multiple trauma patients: an outcome analysis].
Grinţescu I; Tulbure D; Mirea L
Chirurgia (Bucur); 2006; 101(6):615-24. PubMed ID: 17283837
[TBL] [Abstract][Full Text] [Related]
15. Antidotes to haemorrhage: recombinant factor VIIa.
Kessler CM
Best Pract Res Clin Haematol; 2004 Mar; 17(1):183-97. PubMed ID: 15171966
[TBL] [Abstract][Full Text] [Related]
16. Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.
Guzzetta NA; Russell IA; Williams GD
Anesth Analg; 2012 Aug; 115(2):364-78. PubMed ID: 22652310
[TBL] [Abstract][Full Text] [Related]
17. The potential use of recombinant activated factor VII in trauma and surgery.
Sapsford W
Scand J Surg; 2004; 93(1):17-23. PubMed ID: 15116814
[TBL] [Abstract][Full Text] [Related]
18. Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings.
Grounds RM; Bolan C
Crit Care; 2005; 9 Suppl 5(Suppl 5):S29-36. PubMed ID: 16221317
[TBL] [Abstract][Full Text] [Related]
19. Results of the WIRK prospective, non-interventional observational study of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors and other bleeding disorders.
Birschmann I; Klamroth R; Eichler H; Schenk J; Kirchmaier CM; Halimeh S
Haemophilia; 2013 Sep; 19(5):679-85. PubMed ID: 23647644
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIIa in the treatment of bleeding.
Midathada MV; Mehta P; Waner M; Fink LM
Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
